Advertisement

Topics

Anglo-Japanese collaboration on novel therapeutics in inflammatory disease

08:12 EDT 29 Jun 2017 | thePharmaLetter

UK-based Heptares Therapeutics, a wholly-owned subsidiary of Japan’s Sosei Group, and PeptiDream have…

Original Article: Anglo-Japanese collaboration on novel therapeutics in inflammatory disease

NEXT ARTICLE

More From BioPortfolio on "Anglo-Japanese collaboration on novel therapeutics in inflammatory disease"

Quick Search
Advertisement